Novo Holdings A/S 13D and 13G filings for CYTEIR THERAPEUTICS INC:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-08-03 5:02 pm Sale | 2023-07-28 | 13D | CYTEIR THERAPEUTICS INC CYTT | Novo Holdings A/S | 1,547,136 4.400% | -1,525,000 (-49.64%) | Filing |
| 2023-07-26 4:58 pm Sale | 2023-07-20 | 13D | CYTEIR THERAPEUTICS INC CYTT | Novo Holdings A/S | 3,072,136 8.700% | -868,277 (-22.04%) | Filing |
| 2022-09-30 4:42 pm Unchanged | 2022-09-27 | 13D | CYTEIR THERAPEUTICS INC CYTT | Novo Holdings A/S | 3,940,413 11.100% | 0 (Unchanged) | Filing |
| 2022-07-22 6:37 pm Sale | 2022-07-20 | 13D | CYTEIR THERAPEUTICS INC CYTT | Novo Holdings A/S | 3,940,413 11.100% | -900,000 (-18.59%) | Filing |
| 2021-12-20 1:00 pm Unchanged | 2021-12-15 | 13D | CYTEIR THERAPEUTICS INC CYTT | Novo Holdings A/S | 4,840,413 13.600% | 0 (Unchanged) | Filing |
| 2021-06-25 4:33 pm Purchase | 2021-06-17 | 13D | CYTEIR THERAPEUTICS INC CYTT | Novo Holdings A/S | 4,840,413 14.000% | 4,840,413 (New Position) | Filing |